Dawn P.X. Lau

Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors

F. Chong, A. Vettore, X. Kwang, 2024, Developmental Cell.